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ReportsCharacteristic Needle-Shaped
Pattern Seen on OCT in a
Patient with Ocular
AmyloidosisFamilial amyloidosis is an inherited disorder that involves amyloid
deposition in various tissues and organs. The most common mu-
tation is in transthyretin (TTR) protein, which carries thyroxine and
vitamin A.1 Transthyretin is synthesized mainly in the liver, but
also in the retinal pigment epithelium and choroid plexus.
Patients with amyloidosis TTR (ATTR) most frequently have
neurological and cardiac involvement.2 However, ocular
involvement can be the presenting manifestation. This is a case
report of a patient diagnosed with ATTR with ocular
involvement and a characteristic OCT pattern. This is the second
documented case reported of ocular amyloidosis and this OCT
pattern.3
Case Report
This study was approved by the Moorfields Eye Hospital institu-
tional review board. The protocol adhered to the tenets of the
Declaration of Helsinki, and informed consent from the patient was
obtained. A 69-year-old White British man sought treatment at the
uveitis clinic at Moorfields Eye Hospital in March 2017 with sig-
nificant bilateral visual deterioration. The patient had a history of
bilateral vitritis since 2010 and previous bilateral vitrectomies. The
histopathologic analysis of the left eye vitreous, obtained at vitrec-
tomy performed in January 2012, showed fibrin clot and acellular
debris, with no significant cellular fraction or malignant cells. The
histopathologic analysis of the right eye vitreous, obtained at vit-
rectomy inMarch 2012, demonstrated an epiretinal membrane in the
context of chronic inflammation, but no evidence of neoplasia. The
patient then underwent bilateral cataract operation and
yttriumealuminumegarnet (YAG) posterior capsulotomy and
experienced a few recurrences of intermediate uveitis that were
managed with topical treatment alone. His medical history was sig-
nificant for atrial fibrillation, pulmonary embolism, and pacemaker
implantation for complete heart block, but he had no family history of
amyloidosis.
At presentation, his best-corrected visual acuity, tested with a log-
arithm of the minimum angle of resolution chart, was 0.60 bilaterally,
and the intraocular pressurewaswithin normal limits.Anterior segment
examination showed bilateral mild anterior chamber activity, but no
abnormalities were seen in the conjunctiva, cornea, iris, pupil, or
trabecular meshwork. Dilated funduscopy in the right eye revealed 2
inactive parafoveal scars that had been noted previously, vitreous
opacities, and blot hemorrhages in the retinal periphery. The left eye
harbored an epiretinal membrane and vitreous strands. Fundus fluo-
rescein angiography in the right eye showed vascular staining and
blocking defects corresponding to retinal hemorrhages. Bilaterally,
peripheral hypofluorescence, resulting from capillary nonperfusion,was present. OCT in the right eye showed subtle thickening of the in-
ternal limiting membrane (ILM) with 2 parafoveal scars. However, in
the left eye, retinal surface deposits with a needle-shaped pattern
extending from the ILM to the vitreous were present (Fig 1).
Because he experienced recurrence of the vitritis, we performed
another right-eye vitreous biopsy that showed eosinophil amor-
phous material, consistent with amyloid (Congo red staining and
green birefringence), but no evidence of lymphoma or malignancy.
Subsequently, we referred the patient to the National Amyloidosis
Centre, where he was diagnosed with ATTR associated with the
V30MTTR variant (late-onset) with cardiac involvement and
small-fiber neuropathy.
Three months later, best-corrected visual acuity was 0.47
bilaterally and OCT of the left eye revealed slight progression of
the previous findings. In January 2019, the patient was referred
again because he had increased floaters in his left eye. On exam-
ination, no active inflammation was found, but persistent left eye
vitreous strands were found, accounting for his visual symptoms. A
further vitrectomy in the left eye was undertaken for visual
improvement, and this was achieved. OCT of the right eye showed
persistent mild ILM thickening, and OCT of the left eye showed
persistent retinal surface depositions, as shown in Figures 2 and 3
(available at www.ophthalmologyretina.org).Discussion
Familial amyloidosis was described first by Andrade4 in 1952 in a
group of patients with the ATTR changing valine at amino acid 30
to methionine (Val30Met) mutation. The amyloidogenic mutated
proteins identified are TTR, apolipoprotein A-I, and gelsolin. The
ATTR Val30Met is the most common mutation in the TTR gene
and accounts for the substitution of methionine for valine at
position 30 of protein ATTR.5
The most prevalent ocular manifestation in ATTR is the pres-
ence of vitreous amyloid deposits causing visual deterioration. The
vitreous involvement usually is bilateral, but asymmetric.6
Vitrectomy may improve the visual acuity, but the amyloid
deposits may recur. Other ocular features are abnormal
conjunctival vessels, neurotrophic keratitis, deposits on the
pupillary border and lens, glaucoma, and retinal vein occlusion.
Our patient demonstrated bilateral vitreous opacities and retinal
ischemia, but no glaucoma and no conjunctival, corneal, or pu-
pillary involvement. Bilaterally, the vitreous opacities regressed
after the first vitrectomy, but recurred after some years, and the
patient underwent a further vitrectomy, which gave the diagnosis
of amyloidosis on histologic examination. According to a 2011
study by Beirão et al,7 recurrence of vitreous amyloidosis in 44
vitrectomized eyes represented no true recurrence, but rather was
associated with incomplete vitrectomy.
Regarding the OCT findings, the left eye showed ILM thick-
ening with needle-shaped deposits, presumably depicting the
amyloid deposition on the retinal surface that persists after1
Figure 1. Fundus photographs and OCT scans from both eyes obtained in March 2017. Top row, Fundus photographs from both eyes showing vitreous
opacities. Second row, OCT scans of the right eye (RE) showing mild thickening of the internal limiting membrane and of the left eye (LE) showing needle-
shaped deposits on the retinal surface (yellow contour in Second and Third row).
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not the characteristic deposits. This asymmetry between the 2 eyes
may be associated with the asymmetric nature of vitreous
amyloidosis3,6 or with incomplete vitrectomy and remaining
amyloid deposits.
We decided to report this case because it is the second case
described in the literature with ocular amyloidosis and this char-
acteristic OCT pattern, identified after vitrectomy. The first case
was described in 2008 by Hattori et al.3 They reported a 59-year-
old patient with bilateral vitreous opacities, deposits on the
pupillary border, and neovascular glaucoma, possibly associated
with retinal vascular disease. His findings were asymmetric
between the 2 eyes and were more prominent in the right eye.
The vitreous obtained at vitrectomy of this eye showed ocular
amyloidosis, and the OCT demonstrated characteristic needle-
shaped amyloid deposits on the retinal surface.2
In conclusion, in ocular amyloidosis, vitrectomy is the gold
standard to confirm the diagnosis of vitreous involvement. How-
ever, if there are patients with this unusual OCT presentation after
vitrectomy, ophthalmologists should consider amyloidosis as a
differential diagnosis and should conduct further investigations
because the patient may have serious organ involvement such as is
seen in the heart. This OCT pattern therefore may contribute to the
earlier diagnosis of ocular and systemic amyloidosis.
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